![Robert W. Buckheit](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert W. Buckheit
Directeur Technique/Scientifique/R&D chez
STATERA BIOPHARMA, INC.
Profil
Robert W.
Buckheit was the founder of ImQuest Life Sciences, Inc. (2004) as Director, Chief Specific Officer & EVP and ImQuest BioSciences, Inc. (2004) as President & Chief Scientific Officer.
Current jobs include Director at Frederick Innovative Technology Center, Inc., President at The International Society for Antiviral Research, and Chief Technology Officer at Statera Biopharma, Inc. Former jobs include Chief Technology Officer at Cleveland BioLabs, Inc. and Chief Technology Officer at Cytocom, Inc. Education includes a doctorate from Duke University (1986) and an undergraduate degree from Lehigh University (1982).
Postes actifs de Robert W. Buckheit
| Sociétés | Poste | Début |
|---|---|---|
| STATERA BIOPHARMA, INC. | Directeur Technique/Scientifique/R&D | 27/07/2021 |
Frederick Innovative Technology Center, Inc. | Directeur/Membre du Conseil | - |
The International Society for Antiviral Research
 The International Society for Antiviral Research Miscellaneous Commercial ServicesCommercial Services Operates a global institution for the sharing of scientific developments in anti viral medicines | President | - |
ImQuest BioSciences, Inc.
 ImQuest BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates preclinical contract research and development organization for biotechnology and pharmaceutical industries | Fondateur | 01/01/2004 |
Anciens postes connus de Robert W. Buckheit
| Sociétés | Poste | Fin |
|---|---|---|
| STATERA BIOPHARMA, INC. | Directeur Technique/Scientifique/R&D | - |
Cytocom, Inc. /Old/
 Cytocom, Inc. /Old/ BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops novel small molecule immunotherapies | Directeur Technique/Scientifique/R&D | - |
ImQuest Life Sciences, Inc.
 ImQuest Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer, inflammation and infectious disease treatments | Fondateur | - |
Formation de Robert W. Buckheit
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
95
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Cleveland BioLabs, Inc.
 Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to activate the immune system and address serious medical needs | Health Technology |
ImQuest Life Sciences, Inc.
ImQuest Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer, inflammation and infectious disease treatments | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lehigh University
 Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The International Society for Antiviral Research
The International Society for Antiviral Research Miscellaneous Commercial ServicesCommercial Services Operates a global institution for the sharing of scientific developments in anti viral medicines | Commercial Services |
ImQuest BioSciences, Inc.
ImQuest BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates preclinical contract research and development organization for biotechnology and pharmaceutical industries | Commercial Services |
Frederick Innovative Technology Center, Inc. | |
Cytocom, Inc. /Old/
Cytocom, Inc. /Old/ BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops novel small molecule immunotherapies | Health Technology |
Statera Biopharma, Inc.
 Statera Biopharma, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops novel small molecule immunotherapies | Health Technology |
